29 June 2023

Champalimaud Research Annual Retreat 2023

The 2023 retreat took place at the Grande Hotel do Luso, in the beautiful Serra do Buçaco, from 29 May to 1 June, with the participation of more than 250 CR members. The theme of this year’s retreat was Embracing Multitudes: a Game of Translation which aimed at building bridges between the diverse research areas of CR, from neuroscience, cancer biology and immunology, to translational clinical research. The focus was on the diversity that shapes our institute and how to create a cohesive and collaborative community.

21 June 2023

One big problem with the detection of prostate cancer is that it is purely based on the visual perception of radiologists looking at MRI exams

Interview with Nikos Papanikolaou, principal investigator of the Computational Clinical Imaging Group.

15 June 2023

From promise to practice: a dose of reality for psychedelic therapies

The exploration of alternative therapeutics for hard-to-treat mental health disorders has brought into focus an array of psychedelics such as psilocybin, present in ‘magic mushrooms’, and LSD, substances once associated more with counterculture than clinical practice. Alongside ‘atypical’ psychedelics like ketamine and MDMA, these substances are increasingly being recognised for their potential therapeutic attributes.

23 August 2023

Bouncing back from mistakes: how brain state improves decisions

The Constant Chatter of Neurons

“The brain isn’t like a computer that turns off when it’s not doing a particular task”, explains Alfonso Renart, the senior author of the study published in eLife. “There’s always a kind of background hum, a baseline activity that can sometimes make it seem as if the brain is chattering to itself”. The team’s study lifts the lid on how that baseline activity, the continuous stream of electrical impulses sent by neurons, impacts behaviour and decision-making.

25 May 2023

How animals use smell to determine the identity and position of other animals

Many animals rely on smell to identify and locate objects in their surroundings and to respond appropriately. To investigate this phenomenon further, Greg Jefferis’ group in the LMB’s Neurobiology Division established a collaboration with the Behavior and Metabolism Lab, lead by Carlos Ribeiro, at the Champalimaud Foundation (CF) and the group of  Drosophila Connectomics at Cambridge University and together studied Drosophila flies.

11 May 2023

A new maestro identified in gastric cancer cell communication

The work, recently published in prestigious scientific journal PNAS, also shows that this molecule, which is transported by extracellular vesicles produced by tumor cells, directs these vesicles to the liver and lung, precisely the organs where it is common for stomach cancer metastases to appear. With these discoveries, the team contributed to the understanding of a new communication mechanism of tumor cells, thus identifying a potential new goal in developing targeted therapies to stop metastasis.

13 April 2023

One brain, multiple and simultaneous alternative decision strategies

A study published today, April 13th, in the journal Nature Neuroscience provides a surprising answer to this question by showing that, rather than committing to a single strategy, the brain can compute multiple alternative decision strategies simultaneously.

The study, led by Fanny Cazettes and senior authors Zachary Mainen and Alfonso Renart, at the Champalimaud Foundation in Lisbon, Portugal, performed a specially-designed experiment which used a kind of “virtual reality” setup for mice, in which the animals were tasked with searching for water in a virtual world. 

30 March 2023

The European Research Council awards four ERC Advanced Grants to Life Sciences in Portugal

In Portugal, the winning scientists are Isabel Gordo (Gulbenkian Institute of Science, IGC), Maria Manuel Mota (João Lobo Antunes Institute of Molecular Medicine, iMM), Mariana Pinho (ITQB-NOVA) and Henrique Veiga-Fernandes (Champalimaud Foundation). Each will receive between €2.5M and €3.5M for the development of research projects over the next five years.

16 February 2023

When scientists and doctors collaborate, the result can be a potential game-changer

Scientists and doctors at the Champalimaud Foundation, in Lisbon, have joined efforts to reduce the toxicity of so-called “neoadjuvant chemoradiation” – the combination of chemotherapy plus radiotherapy – for the treatment of rectal cancer. If further confirmed, their results, published a few months ago in the journal Frontiers in Oncology, could in the not-so-distant future help many patients with rectal cancer, especially the more elderly and frail ones.

06 February 2023

Study suggests the brain works like a resonance chamber

It’s been over 20 years since neuroimaging studies – using functional magnetic resonance imaging (fMRI), a widely-used technology to capture live videos of brain activity – have been detecting brain-wide complex patterns of correlated brain activity that appear disrupted in a wide range of neurological and psychiatric disorders. These patterns form spontaneously, even at rest when no particular task is being performed, and have been detected not only in humans but also across mammals, including monkeys and rodents. 

Subscribe to Champalimaud Research
Loading
Please wait...